SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-000934
Filing Date
2024-02-09
Accepted
2024-02-09 16:06:07
Documents
110
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q ibio-20231231x10q.htm   iXBRL 10-Q 2284353
2 EX-31.1 ibio-20231231xex31d1.htm EX-31.1 15718
3 EX-31.2 ibio-20231231xex31d2.htm EX-31.2 18743
4 EX-32.1 ibio-20231231xex32d1.htm EX-32.1 10597
5 EX-32.2 ibio-20231231xex32d2.htm EX-32.2 6713
6 GRAPHIC ibio-20231231x10q001.jpg GRAPHIC 84419
7 GRAPHIC ibio-20231231x10q002.jpg GRAPHIC 79390
8 GRAPHIC ibio-20231231x10q003.jpg GRAPHIC 70535
9 GRAPHIC ibio-20231231x10q004.jpg GRAPHIC 76117
  Complete submission text file 0001558370-24-000934.txt   12415464

Data Files

Seq Description Document Type Size
10 EX-101.SCH ibio-20231231.xsd EX-101.SCH 116386
11 EX-101.CAL ibio-20231231_cal.xml EX-101.CAL 81328
12 EX-101.DEF ibio-20231231_def.xml EX-101.DEF 385673
13 EX-101.LAB ibio-20231231_lab.xml EX-101.LAB 699310
14 EX-101.PRE ibio-20231231_pre.xml EX-101.PRE 643129
112 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20231231x10q_htm.xml XML 2024378
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 24614787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)